LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
Übersicht
Veränderung der Aktienkurses
24h
Aktuell
Min
84.42
Max
85.99
Empfehlungen | Buy |
---|---|
12-Monats-Prognose | +32.79 upside |
Nächstes Ergebnis | 5. Aug. 2024 |
---|
Technischer Score
By Trading Central
Vertrauen
Bearish Evidence
84.25 / 85.97 Unterstützung & Widerstand
BioNTech SE ADR Chart
Ähnliche Nachrichten
6. Mai 2024, 11:27 UTC
BioNTech Swings to Net Loss on Lower Covid Vaccine Sales
DJ
Lesen
20. März 2024, 10:44 UTC
BioNTech Profit Slumps on Lower Covid Vaccine Sales
DJ
Lesen
8. Feb. 2024, 11:43 UTC
BioNTech Agrees To Invest $200 Million in Autolus, Starts Strategic Collaboration
DJ
Lesen
9. Jan. 2024, 19:42 UTC
BioNTech Shares Down 3.4%; Sees 2024 Revenue Below Wall Street Views
DJ
Lesen
19. Dez. 2023, 16:57 UTC
CureVac Shares Hit All-Time Low on German Patent Court Ruling
DJ
Lesen
13. Dez. 2023, 13:16 UTC
Moderna Shares, Other Covid Vaccine Makers Hit by Warning From Pfizer
DJ
Lesen
6. Nov. 2023, 19:07 UTC
Trending: BioNTech Reports Surprise Profit, Cuts Outlook
DJ
Lesen
6. Mai 2024, 20:15 UTC
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come -- IBD
DJ
Lesen
6. Mai 2024, 10:47 UTC
BioNTech Sees FY24 Rev EUR2.5B-EUR3.1B >BNTX
DJ
Lesen
6. Mai 2024, 10:46 UTC
Correct: BioNTech 1Q Loss/Shr EUR1.31 >BNTX
DJ
Lesen
6. Mai 2024, 10:46 UTC
Correct: BioNTech 1Q Loss EUR315.1M >BNTX
DJ
Lesen
6. Mai 2024, 10:46 UTC
Correct: BioNTech 1Q Rev EUR187.6M >BNTX
DJ
Lesen
6. Mai 2024, 10:45 UTC
BioNTech 1Q Rev $187.6M >BNTX
DJ
Lesen
6. Mai 2024, 10:45 UTC
BioNTech 1Q Loss $315.1M >BNTX
DJ
Lesen
6. Mai 2024, 10:45 UTC
BioNTech 1Q Loss/Shr $1.31 >BNTX
DJ
Lesen
26. März 2024, 05:00 UTC
This Vaccine Maker Sits on Cash Almost Equal to Its Market Value -- Barrons.com
DJ
Lesen
20. März 2024, 11:44 UTC
BioNTech Earnings Fall Short of Estimates. The Stock Is Down. -- Barrons.com
DJ
Lesen
20. März 2024, 10:27 UTC
BioNTech's Stock Sinks After Earnings Fall Below Expectations, Hurt By Writedowns Of Vaccine Inventory -- MarketWatch
DJ
Lesen
20. März 2024, 10:17 UTC
BioNTech 4Q Rev EUR1.48B >BNTX
DJ
Lesen
20. März 2024, 10:15 UTC
Biontech 4Q Net Pft EUR457.9M
DJ
Lesen
20. März 2024, 10:15 UTC
Biontech Plans For Ten or More Registrational Oncology Trials By End of 2024
DJ
Lesen
20. März 2024, 10:15 UTC
Biontech: Annemarie Hanekamp appointed to Management Board as Chief Commercial Officer, effective Jul. 1
DJ
Lesen
20. März 2024, 10:15 UTC
Biontech Aims For First Oncology Launch in 2026 and Ten Indication Approvals by 2030
DJ
Lesen
20. März 2024, 10:15 UTC
Biontech 2023 Gross Profit For COVID-19 Vaccine Business EUR3.2B
DJ
Lesen
20. März 2024, 10:15 UTC
Biontech Sees 2024 Revenue Between EUR2.5B - EUR3.1B
DJ
Lesen
20. März 2024, 10:15 UTC
Biontech 4Q Rev EUR1.48B
DJ
Lesen
8. Feb. 2024, 11:28 UTC
BioNTech Agrees To Invest $200 Mln in Autolus, Starts Strategic Collaboration
DJ
Lesen
9. Jan. 2024, 19:27 UTC
BioNTech Shares Down 3.4%; Sees 2024 Rev Below Wall Street Views
DJ
Lesen
15. Dez. 2023, 16:44 UTC
Barron's Favorite 10 Stocks for 2024 -- -2-
DJ
Lesen
15. Dez. 2023, 16:44 UTC
Barron's Favorite 10 Stocks for 2024 -- Barrons.com
DJ
Lesen
Peer-Vergleich
Kursveränderung
BioNTech SE ADR Prognose
Kursziel
By TipRanks
12-Monats-Prognose
Durchschnitt 112.45 USD 32.79%
Hoch 171 USD
Tief 90 USD
Basierend auf 13 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für BioNTech SE ADR – Dist angeboten haben.
Rating-Konsens
By TipRanks
Buy
13 ratings
5
Buy
7
Halten
1
Sell
Basierend auf 13 Analysten, die in den letzten 3 Monaten Aktienbewertungen für BioNTech SE ADR – Dist abgegeben haben.
Technischer Score
By Trading Central
Kurzfristig
Bearish Evidence
Recent bearish events outweigh bullish events.
Mittelfristig
Weak Bearish Evidence
There is one bearish event.
Langfristig
Bearish Evidence
All events are bearish.